These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8343231)

  • 1. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.
    Campbell SE; Janicki JS; Matsubara BB; Weber KT
    Am J Hypertens; 1993 Jun; 6(6 Pt 1):487-95. PubMed ID: 8343231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
    Brilla CG; Weber KT
    Cardiovasc Res; 1992 Jul; 26(7):671-7. PubMed ID: 1423431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with reactive and reparative fibrosis of the myocardium.
    Weber KT; Brilla CG
    Basic Res Cardiol; 1992; 87 Suppl 1():291-301. PubMed ID: 1497573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
    Brilla CG; Weber KT
    J Lab Clin Med; 1992 Dec; 120(6):893-901. PubMed ID: 1453111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism.
    Brilla CG; Matsubara LS; Weber KT
    J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension.
    Brilla CG; Matsubara LS; Weber KT
    Am J Cardiol; 1993 Jan; 71(3):12A-16A. PubMed ID: 8421998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone and myocardial fibrosis in heart failure.
    Brilla CG
    Herz; 2000 May; 25(3):299-306. PubMed ID: 10904856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis.
    Silver MA; Pick R; Brilla CG; Jalil JE; Janicki JS; Weber KT
    Cardiovasc Res; 1990 Sep; 24(9):741-7. PubMed ID: 2146020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.
    Campbell SE; Janicki JS; Weber KT
    J Mol Cell Cardiol; 1995 Aug; 27(8):1545-60. PubMed ID: 8523418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial fibrosis and the concepts of cardioprotection and cardioreparation.
    Weber KT; Brilla CG; Campbell SE; Reddy HK
    J Hypertens Suppl; 1992 Jul; 10(5):S87-94. PubMed ID: 1403238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic mineralocorticoid excess and cardiovascular remodeling.
    Weber KT; Sun Y; Campbell SE; Slight SH; Ganjam VK; Griffing GT; Swinfard RW; Diaz-Arias AA
    Steroids; 1995 Jan; 60(1):125-32. PubMed ID: 7792797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
    Park JB; Schiffrin EL
    Am J Hypertens; 2002 Feb; 15(2 Pt 1):164-9. PubMed ID: 11863252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.
    Sun Y; Ramires FJ; Weber KT
    Cardiovasc Res; 1997 Jul; 35(1):138-47. PubMed ID: 9302358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoids, salt, hypertension: effects on the heart.
    Young MJ; Funder JW
    Steroids; 1996 Apr; 61(4):233-5. PubMed ID: 8733007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
    Sun Y; Ratajska A; Zhou G; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):395-403. PubMed ID: 8228553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac structural remodelling after treatment of spontaneously hypertensive rats with nifedipine or nisoldipine.
    Campbell SE; Turek Z; Rakusan K; Kazda S
    Cardiovasc Res; 1993 Jul; 27(7):1350-8. PubMed ID: 8252599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
    Ramires FJ; Sun Y; Weber KT
    J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
    Young M; Head G; Funder J
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E657-62. PubMed ID: 7485478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
    Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
    Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
    Mirkovic S; Seymour AM; Fenning A; Strachan A; Margolin SB; Taylor SM; Brown L
    Br J Pharmacol; 2002 Feb; 135(4):961-8. PubMed ID: 11861324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.